TP53 Mutation Status and Biopsy Lesion Type Determine the Immunotherapeutic Stratification in Non-Small-Cell Lung Cancer

by Jun Lu, Jun Lu, Jun Lu, Runbo Zhong, Yuqing Lou, Minjuan Hu, Zhengyu Yang, Yanan Wang, Ya Chen, Benkun Zou, Wei Zhang, Huimin Wang, Baohui Han, Baohui Han, Baohui Han
Published 2021-09-01

A host lipase prevents lipopolysaccharide-induced foam cell formation

by Jintao Feng, Wei Jiang, Xiaofang Cheng, Benkun Zou, Alan W. Varley, Ting Liu, Guojun Qian, Wenjiao Zeng, Jianguo Tang, Qiang Zhao, Yiwei Chu, Yuanyuan Wei, Xiaobo Li, Robert S. Munford, Mingfang Lu
Published 2021-09-01

ctDNA-Profiling-Based UBL Biological Process Mutation Status as a Predictor of Atezolizumab Response Among TP53-Negative NSCLC Patients

by Jun Lu, Jun Lu, Jun Lu, Yanwei Zhang, Yuqing Lou, Bo Yan, Bo Yan, Benkun Zou, Minjuan Hu, Yanan Wang, Ya Chen, Zhengyu Yang, Huimin Wang, Wei Zhang, Baohui Han, Baohui Han, Baohui Han
Published 2021-09-01

Acyloxyacyl hydrolase promotes the resolution of lipopolysaccharide-induced acute lung injury.

by Benkun Zou, Wei Jiang, Han Han, Jing Li, Weiying Mao, Zihui Tang, Qian Yang, Guojun Qian, Jing Qian, Wenjiao Zeng, Jie Gu, Tianqing Chu, Ning Zhu, Wenhong Zhang, Dapeng Yan, Rui He, Yiwei Chu, Mingfang Lu
Published 2017-06-01